BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 215] [Cited by in F6Publishing: 229] [Article Influence: 53.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu B, Wang S, Sun R, Ding H, Li L. Hydrogen sulfide promotes the stemness of liver cancer stem cells through the Wnt/β-catenin signaling pathway.. [DOI: 10.21203/rs.3.rs-2540630/v1] [Reference Citation Analysis]
2 Saikia Q, Hazarika A, Kalita JC. Isoliquiritigenin ameliorates paroxetine-induced sexual dysfunction in male albino mice. Reprod Toxicol 2023;:108341. [PMID: 36740106 DOI: 10.1016/j.reprotox.2023.108341] [Reference Citation Analysis]
3 Gai Z, Samodelov SL, Alecu I, Hornemann T, Grove JI, Aithal GP, Visentin M, Kullak-ublick GA. Plasma Sphingoid Base Profiles of Patients Diagnosed with Intrinsic or Idiosyncratic Drug-induced Liver Injury. IJMS 2023;24:3013. [DOI: 10.3390/ijms24033013] [Reference Citation Analysis]
4 Shen XL, Guo YN, Lu MH, Ding KN, Liang SS, Mou RW, Yuan S, He YM, Tang LP. Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating TLR4-NF-κB-MAPK inflammatory response in mice. Ecotoxicol Environ Saf 2023;252:114590. [PMID: 36738614 DOI: 10.1016/j.ecoenv.2023.114590] [Reference Citation Analysis]
5 Ali FE, Abd El-Aziz MK, Sharab EI, Bakr AG. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review. World J Hepatol 2023;15:19-40. [PMID: 36744165 DOI: 10.4254/wjh.v15.i1.19] [Reference Citation Analysis]
6 Ochieng PJ, Hussain A, Dombi J, Krész M. An efficient weighted network centrality approach for exploring mechanisms of action of the Ruellia herbal formula for treating rheumatoid arthritis. Appl Netw Sci 2023;8:7. [DOI: 10.1007/s41109-022-00527-2] [Reference Citation Analysis]
7 Liang H, Yan Z, Tong Y, Chen S, Li J, Chen L, Yang H. Circular bivalent aptamers enhance the activation of the regenerative signaling pathway for repairing liver injury in vivo. Chem Commun (Camb) 2023. [PMID: 36661386 DOI: 10.1039/d2cc06176g] [Reference Citation Analysis]
8 Chen Y, Wang Y, Jiang S, Xu J, Wang B, Sun X, Zhang Y. Red-fleshed apple flavonoid extract alleviates CCl(4)-induced liver injury in mice. Front Nutr 2022;9:1098954. [PMID: 36742007 DOI: 10.3389/fnut.2022.1098954] [Reference Citation Analysis]
9 Zhang J, Gao B, Ye B, Sun Z, Qian Z, Yu L, Bi Y, Ma L, Ding Y, Du Y, Wang W, Mao Z. Mitochondrial-Targeted Delivery of Polyphenol-Mediated Antioxidases Complexes against Pyroptosis and Inflammatory Diseases. Adv Mater 2023;:e2208571. [PMID: 36648306 DOI: 10.1002/adma.202208571] [Reference Citation Analysis]
10 Guo C, Liu W, Liu Z, Cai J, Yu X, Wang H, Li X, Zuo D, Jiang X, Zhang B, Liu J, Sanyal AJ, Puri P, Zhou H, Wang XY. Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury. Hepatology 2023. [PMID: 36632993 DOI: 10.1097/HEP.0000000000000044] [Reference Citation Analysis]
11 Chu MT, Chang WC, Pao SC, Hung SI. Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators. Biomedicines 2023;11. [PMID: 36672685 DOI: 10.3390/biomedicines11010177] [Reference Citation Analysis]
12 Liu Y, Li H, Huang L, Wan C, Wang H, Jiao X, Zeng L, Jia Z, Cheng G, Zhang L, Zhang W, Zhang L. Liver Injury in Children: Signal Analysis of Suspected Drugs Based on the Food and Drug Administration Adverse Event Reporting System.. [DOI: 10.21203/rs.3.rs-2435773/v1] [Reference Citation Analysis]
13 Villa-Jaimes GS, Moshage H, Avelar-González FJ, González-Ponce HA, Buist-Homan M, Guevara-Lara F, Sánchez-Alemán E, Martínez-Hernández SL, Ventura-Juárez J, Muñoz-Ortega MH, Martínez-Saldaña MC. Molecular and Antioxidant Characterization of Opuntia robusta Fruit Extract and Its Protective Effect against Diclofenac-Induced Acute Liver Injury in an In Vivo Rat Model. Antioxidants (Basel) 2023;12. [PMID: 36670975 DOI: 10.3390/antiox12010113] [Reference Citation Analysis]
14 Wang Y, Xie W. Drug-induced liver injury: An overview and update. Gastroenterology & Endoscopy 2023. [DOI: 10.1016/j.gande.2022.11.005] [Reference Citation Analysis]
15 Li J, Qian H, Pi F. Effects of torularhodin against acetaminophen induced liver injury base on antioxidation, anti-inflammation and anti-apoptosis. Food Bioscience 2023. [DOI: 10.1016/j.fbio.2023.102388] [Reference Citation Analysis]
16 Abdel Halim AS, Rudayni HA, Chaudhary AA, Ali MAM. MicroRNAs: Small molecules with big impacts in liver injury. J Cell Physiol 2023;238:32-69. [PMID: 36317692 DOI: 10.1002/jcp.30908] [Reference Citation Analysis]
17 Wang YF, Ma RX, Zou B, Li J, Yao Y, Li J. Endoplasmic reticulum stress regulates autophagic response that is involved in Saikosaponin a-induced liver cell damage. Toxicol In Vitro 2022;88:105534. [PMID: 36539104 DOI: 10.1016/j.tiv.2022.105534] [Reference Citation Analysis]
18 Liu B, Wang S, Xu M, Ma Y, Sun R, Ding H, Li L. The double-edged role of hydrogen sulfide in the pathomechanism of multiple liver diseases. Front Pharmacol 2022;13:899859. [PMID: 36588686 DOI: 10.3389/fphar.2022.899859] [Reference Citation Analysis]
19 Lin J, Li M, Mak W, Shi Y, Zhu X, Tang Z, He Q, Xiang X. Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 2022;10. [PMID: 36548621 DOI: 10.3390/toxics10120788] [Reference Citation Analysis]
20 Zhang M, Zhao X, Li W, Wang X, Niu M, Zhang H, Chen Y, Kong D, Gao Y, Guo Y, Bai Z, Xiao X, Zhao Y, Tang J. Yin/Yang associated differential responses to Psoralea corylifolia Linn. in rat models: an integrated metabolomics and transcriptomics study.. [DOI: 10.21203/rs.3.rs-2301287/v1] [Reference Citation Analysis]
21 Zachou M, Pikramenos K, Panoutsakou M, Lalla E, Androutsakos T. Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report. Cureus 2022;14:e32525. [PMID: 36654618 DOI: 10.7759/cureus.32525] [Reference Citation Analysis]
22 Sokar SS, Alkabbani MA, Akool E, Abu-risha SE. Hepatoprotective effects of carvedilol and crocin against leflunomide-induced liver injury. International Immunopharmacology 2022;113:109297. [DOI: 10.1016/j.intimp.2022.109297] [Reference Citation Analysis]
23 Liu J, Zhao M, Zhao F, Song X, Ye Y. ONOO--triggered fluorescence H2S donor for mitigating drug-induced liver injury. Sensors and Actuators B: Chemical 2022. [DOI: 10.1016/j.snb.2022.133131] [Reference Citation Analysis]
24 Li X, Wang W, Yan S, Zhao W, Xiong H, Bao C, Chen J, Yue Y, Su Y, Zhang C. Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1019487] [Reference Citation Analysis]
25 González-Recio I, Simón J, Goikoetxea-Usandizaga N, Serrano-Maciá M, Mercado-Gómez M, Rodríguez-Agudo R, Lachiondo-Ortega S, Gil-Pitarch C, Fernández-Rodríguez C, Castellana D, Latasa MU, Abecia L, Anguita J, Delgado TC, Iruzubieta P, Crespo J, Hardy S, Petrov PD, Jover R, Avila MA, Martín C, Schaeper U, Tremblay ML, Dear JW, Masson S, McCain MV, Reeves HL, Andrade RJ, Lucena MI, Buccella D, Martínez-Cruz LA, Martínez-Chantar ML. Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage. Nat Commun 2022;13:6816. [PMID: 36433951 DOI: 10.1038/s41467-022-34262-0] [Reference Citation Analysis]
26 Rana P, Khan S, Arat S, Potter D, Khan N. Nonclinical Safety Signals in PharmaPendium Improve the Predictability of Human Drug-Induced Liver Injury. Chem Res Toxicol 2022;35:2133-44. [PMID: 36287557 DOI: 10.1021/acs.chemrestox.2c00243] [Reference Citation Analysis]
27 Yu D, Shao Z, Fu Y, Tang X, Chen Q, Deng Z. Metabolomics- and systems toxicology-based hepatotoxicity mechanism of Sophorae Tonkinensis Radix et Rhizoma in rats. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1015008] [Reference Citation Analysis]
28 Pinazo-bandera JM, García-cortés M, Segovia-zafra A, Lucena MI, Andrade RJ. Recreational Drugs and the Risk of Hepatocellular Carcinoma. Cancers 2022;14:5395. [DOI: 10.3390/cancers14215395] [Reference Citation Analysis]
29 Wang C, Zhao S, Xu Y, Sun W, Feng Y, Liang D, Guan Y. Integrated Microbiome and Metabolome Analysis Reveals Correlations Between Gut Microbiota Components and Metabolic Profiles in Mice with Methotrexate-Induced Hepatoxicity. DDDT 2022;Volume 16:3877-3891. [DOI: 10.2147/dddt.s381667] [Reference Citation Analysis]
30 Stroh J, Smith BJ, Sottile PD, Hripcsak G, Albers DJ. Hypothesis-driven modeling of the human lung-ventilator system: A characterization tool for Acute Respiratory Distress Syndrome research.. [DOI: 10.1101/2022.10.31.514563] [Reference Citation Analysis]
31 Gao Z, Wang D, Zhang H, Yang J, Li M, Lu H, Shen H, Tang Y. An iron-deficient diet prevents alcohol- or diethylnitrosamine-induced acute hepatotoxicity in mice by inhibiting ferroptosis. Current Research in Food Science 2022. [DOI: 10.1016/j.crfs.2022.11.001] [Reference Citation Analysis]
32 Feng S, Zheng J, Zhang J, Gui Z, Feng G. Fe2+ imaging in ferroptosis and drug-induced liver injury with a ratiometric near-infrared fluorescent probe. Sensors and Actuators B: Chemical 2022;371:132512. [DOI: 10.1016/j.snb.2022.132512] [Reference Citation Analysis]
33 Hou W, Nsengimana B, Yan C, Nashan B, Han S. Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury. Front Pharmacol 2022;13:1022809. [DOI: 10.3389/fphar.2022.1022809] [Reference Citation Analysis]
34 Al-Khawalde AAA, Abukhalil MH, Jghef MM, Alfwuaires MA, Alaryani FS, Aladaileh SH, Algefare AI, Karimulla S, Alasmari F, Aldal'in HK, Alanezi AA, Althunibat OY. Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death. Int J Mol Sci 2022;23:12334. [PMID: 36293191 DOI: 10.3390/ijms232012334] [Reference Citation Analysis]
35 Radloff K, Gutbier B, Dunne CM, Moradian H, Gossen M, Ahrens KM, Kneller L, Wang Y, Moga A, Gkionis L, Keil O, Fehring V, Tondera D, Giese K, Santel A, Kaufmann J, Witzenrath M. Spatial expression of an mRNA encoding Tie2-agonist in the capillary endothelium of the lung prevents pulmonary vascular leakage.. [DOI: 10.1101/2022.10.12.511878] [Reference Citation Analysis]
36 Ahmed HM, Shehata HH, El-Saeed GSM, Gabal HHA, El-Daly SM. Ameliorative effect of Lactobacillus rhamnosus GG on acetaminophen-induced hepatotoxicity via PKC/Nrf2/PGC-1α pathway. J Genet Eng Biotechnol 2022;20:142. [PMID: 36201094 DOI: 10.1186/s43141-022-00422-4] [Reference Citation Analysis]
37 Islam MA, Getz M, Macklin P, Versypt ANF. An agent-based modeling approach for lung fibrosis in response to COVID-19. bioRxiv 2022:2022. [PMID: 36238719 DOI: 10.1101/2022.10.03.510677] [Reference Citation Analysis]
38 Kajiwara A, Kawamura Y, Kinowaki K, Muraishi N, Iritani S, Akuta N, Fujiyama S, Sezaki H, Hosaka T, Saitoh S, Kobayashi M, Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kumada H. A case of drug-induced acute liver failure caused by corticosteroids. Clin J Gastroenterol 2022;15:946-952. [DOI: 10.1007/s12328-022-01661-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shao YL, Ma CM, Wu JM, Guo FC, Zhang SC. Concurrent severe hepatotoxicity and agranulocytosis induced by Polygonum multiflorum: A case report. World J Clin Cases 2022; 10(27): 9921-9928 [DOI: 10.12998/wjcc.v10.i27.9921] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M. Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care 2022;26:289. [DOI: 10.1186/s13054-022-04163-1] [Reference Citation Analysis]
41 Di Zeo-sánchez DE, Segovia-zafra A, Matilla-cabello G, Pinazo-bandera JM, Andrade RJ, Lucena MI, Villanueva-paz M. Modeling drug-induced liver injury: current status and future prospects. Expert Opinion on Drug Metabolism & Toxicology. [DOI: 10.1080/17425255.2022.2122810] [Reference Citation Analysis]
42 Biagioli M, Marchianò S, di Giorgio C, Roselli R, Bordoni M, Bellini R, Fiorillo B, Sepe V, Catalanotti B, Cassiano C, Monti MC, Distrutti E, Zampella A, Fiorucci S. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury. Hepatology 2022. [PMID: 36107019 DOI: 10.1002/hep.32787] [Reference Citation Analysis]
43 Maillard M, Arellano C, Vachoux C, Chevreau C, Cabaton NJ, Pont F, Saint-Laurent N, Lafont T, Chatelut E, Thomas F. Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury. Metabolites 2022;12:852. [PMID: 36144257 DOI: 10.3390/metabo12090852] [Reference Citation Analysis]
44 Gong JY, Ren H, Chen HQ, Xing K, Xiao CL, Luo JQ. Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice. Pharmaceuticals (Basel) 2022;15:1130. [PMID: 36145350 DOI: 10.3390/ph15091130] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Acute Pancreatitis: Diagnosis and Treatment. Drugs 2022. [PMID: 36074322 DOI: 10.1007/s40265-022-01766-4] [Reference Citation Analysis]
46 Yang J, Li G, Bao X, Suo Y, Xu H, Deng Y, Feng T, Deng G. Hepatoprotective effects of Phloridzin against isoniazid-rifampicin induced liver injury by regulating CYP450 and Nrf2/HO-1 pathway in mice. Chem Pharm Bull (Tokyo) 2022. [PMID: 36070932 DOI: 10.1248/cpb.c22-00466] [Reference Citation Analysis]
47 Wang Y, Liu Y, Song X, Feng Y, Jing C, Zhang G, Huang Y, Liu W. Dual-targetable fluorescent probe for mapping the fluctuation of peroxynitrite in drug-induced liver injury model. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022. [DOI: 10.1016/j.saa.2022.121892] [Reference Citation Analysis]
48 Sheng C, Zhao J, Di Z, Huang Y, Zhao Y, Li L. Spatially resolved in vivo imaging of inflammation-associated mRNA via enzymatic fluorescence amplification in a molecular beacon. Nat Biomed Eng 2022. [PMID: 36050523 DOI: 10.1038/s41551-022-00932-z] [Reference Citation Analysis]
49 Chen R, Li W, Li R, Ai S, Zhu H, Lin W. Cysteine-activated fluorescence/photoacoustic integrated probe for non-invasive diagnosis of drug-induced liver injury. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107845] [Reference Citation Analysis]
50 Bai Z, Tao W, Zhou Y, Cao Y, Yu S, Shi Z. Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway. Front Pharmacol 2022;13:948128. [DOI: 10.3389/fphar.2022.948128] [Reference Citation Analysis]
51 Shen L, Lv X, Yang X, Deng S, Liu L, Zhou J, Zhu Y, Ma H. Bufotenines-loaded liposome exerts anti-inflammatory, analgesic effects and reduce gastrointestinal toxicity through altering lipid and bufotenines metabolism. Biomedicine & Pharmacotherapy 2022;153:113492. [DOI: 10.1016/j.biopha.2022.113492] [Reference Citation Analysis]
52 Ramos-casals M, Flores-chávez A, Brito-zerón P, Lambotte O, Mariette X. Immune-related adverse events of cancer immunotherapies targeting kinases. Pharmacology & Therapeutics 2022;237:108250. [DOI: 10.1016/j.pharmthera.2022.108250] [Reference Citation Analysis]
53 Liu M, Xiang Y, Yang Y, Long X, Xiao Z, Nan Y, Jiang Y, Qiu Y, Huang Q, Ai K. State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC. Biosensors and Bioelectronics 2022. [DOI: 10.1016/j.bios.2022.114758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Niu H, Atallah E, Alvarez-Alvarez I, Medina-Caliz I, Aithal GP, Arikan C, Andrade RJ, Lucena MI. Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review. Drug Saf 2022. [PMID: 36006605 DOI: 10.1007/s40264-022-01224-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Hu Y, Wu Q, Wang Y, Zhang H, Liu X, Zhou H, Yang T. The molecular pathogenesis of triptolide-induced hepatotoxicity. Front Pharmacol 2022;13:979307. [DOI: 10.3389/fphar.2022.979307] [Reference Citation Analysis]
56 Jia X, Wen X, Russo DP, Aleksunes LM, Zhu H. Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay. J Hazard Mater 2022;436:129193. [PMID: 35739723 DOI: 10.1016/j.jhazmat.2022.129193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
57 Bischoff SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I, Eshraghian A, Kani HT, Khannoussi W, Lacaze L, Léon-Sanz M, Mendive JM, Müller MW, Ockenga J, Tacke F, Thorell A, Vranesic Bender D, Weimann A, Cuerda C. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline. Clin Nutr 2022:S0261-5614(22)00239-4. [PMID: 35970666 DOI: 10.1016/j.clnu.2022.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Katritsis NM, Liu A, Youssef G, Rathee S, Macmahon M, Hwang W, Wollman L, Han N. dialogi: Utilising NLP With Chemical and Disease Similarities to Drive the Identification of Drug-Induced Liver Injury Literature. Front Genet 2022;13:894209. [DOI: 10.3389/fgene.2022.894209] [Reference Citation Analysis]
59 Zeng Z, Yi W, Dong J, Chen Q, Sun F, Lu H, Lin Y, Bi X, Yang L, Lu Y, Zhang L, Li M, Xie Y. Baseline lymphocyte and cholinesterase levels may be the predictors of chronic herbal drug–induced liver injury. Front Pharmacol 2022;13:962480. [DOI: 10.3389/fphar.2022.962480] [Reference Citation Analysis]
60 Wu P, Gao M, Zhang C, Li C, Li G, Yan X, Lai X, Zhang Y, Zhang J. Engineering of Biodegradable and Excretable Inflammation‐Resolving Materials. Adv Funct Materials. [DOI: 10.1002/adfm.202205528] [Reference Citation Analysis]
61 Han YZ, Ma ZT, Zhou MX, Niu M, Zhao X, Guo YM, Song XH, Lu YW, Bai ZF, Li Z, Gao H, Zhao YK, Wang JB, Xiao XH, Jing J. Metabolomic profiling for drug-induced liver injury with autoantibodies. Int Immunopharmacol 2022;111:109084. [PMID: 35932613 DOI: 10.1016/j.intimp.2022.109084] [Reference Citation Analysis]
62 Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int 2022;42:1999-2014. [PMID: 35353431 DOI: 10.1111/liv.15262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
63 Wang Y, Charkoftaki G, Davidson E, Orlicky DJ, Tanguay RL, Thompson DC, Vasiliou V, Chen Y. Oxidative Stress, Glutathione and CYP2E1 in 1,4-Dioxane Liver Cytotoxicity and Genotoxicity: Insights from Animal Models. Current Opinion in Environmental Science & Health 2022. [DOI: 10.1016/j.coesh.2022.100389] [Reference Citation Analysis]
64 Cheng YL, Chang WK, Yen H, Peng YJ, Chang WC, Chang PY. Osimertinib-related liver injury with successful osimertinib rechallenge: A case report. Thorac Cancer 2022. [PMID: 35793806 DOI: 10.1111/1759-7714.14556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Yamauchi R, Takata K, Fukunaga A, Tanaka T, Yokoyama K, Shakado S, Nabeshima K, Yoshimitsu K, Hirai F. Improvement of vanishing bile duct syndrome with hyperlipidemia. Clin J Gastroenterol 2022;15:784-790. [DOI: 10.1007/s12328-022-01650-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Björnsson ES, Stephens C, Atallah E, Robles-Diaz M, Alvarez-Alvarez I, Gerbes A, Weber S, Stirnimann G, Kullak-Ublick G, Cortez-Pinto H, Grove JI, Lucena MI, Andrade RJ, Aithal GP. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry. Liver Int 2023;43:115-26. [PMID: 35899490 DOI: 10.1111/liv.15378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Mun SJ, Lee J, Shin Y, Son MJ. Advanced human liver models for the assessment of drug-induced liver injury. Organoid 2022;2:e17. [DOI: 10.51335/organoid.2022.2.e17] [Reference Citation Analysis]
68 Liu Z, Li T, Connor S, Thakkar S, Roberts R, Tong W. Best practice and reproducible science are required to advance artificial intelligence in real-world applications. Brief Bioinform 2022;23:bbac237. [PMID: 35848999 DOI: 10.1093/bib/bbac237] [Reference Citation Analysis]
69 Yen NTH, Park SM, Thu VTA, Phat NK, Cho YS, Yoon S, Shin JG, Kim DH, Oh JH, Long NP. Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents. Life Sci 2022;306:120801. [PMID: 35850247 DOI: 10.1016/j.lfs.2022.120801] [Reference Citation Analysis]
70 Osorio-sandoval G, Mejía-vargas NJ, Pérez-cadavid JC, Cardona-palacio A. Hiperbilirrubinemia: visión del patólogo. Hepatología 2022. [DOI: 10.52784/27112330.157] [Reference Citation Analysis]
71 He Z, Zeng Y, Li S, Lin L, Zhou R, Wang F, Yang W, Wu Y, Yang J, Chen A, Wang Z, Yang H, Zhao X, Xiao W, Li L, Gong S. Gut Commensal Fungi Protect Against Acetaminophen-Induced Hepatotoxicity by Reducing Cyp2a5 Expression in Mice. Front Microbiol 2022;13:944416. [DOI: 10.3389/fmicb.2022.944416] [Reference Citation Analysis]
72 von Samson-himmelstjerna FA, Kolbrink B, Riebeling T, Kunzendorf U, Krautwald S. Progress and Setbacks in Translating a Decade of Ferroptosis Research into Clinical Practice. Cells 2022;11:2134. [DOI: 10.3390/cells11142134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Inam Sameh Arif, Israa Burhan Raoof, Hayder Hussein Luaibi, Shams Khaleel Ibraheem. Role of miRNA in drug-induced hepatic injury. AJPS 2022;22:1-6. [DOI: 10.32947/ajps.v22i2.833] [Reference Citation Analysis]
74 Zhao L, Yu Y, Li L, Wang J, Wang J, Su S, Ding J, Zhang Y, Wang A, Zhou K. Isobavachalcone disrupts mitochondrial respiration and induces cytotoxicity through ROS accumulation and Akt suppression. Toxicon 2022;216:28-36. [PMID: 35780971 DOI: 10.1016/j.toxicon.2022.06.018] [Reference Citation Analysis]
75 Frtús A, Smolková B, Uzhytchak M, Lunova M, Jirsa M, Henry SJW, Dejneka A, Stephanopoulos N, Lunov O. The interactions between DNA nanostructures and cells: A critical overview from a cell biology perspective. Acta Biomater 2022;146:10-22. [PMID: 35523414 DOI: 10.1016/j.actbio.2022.04.046] [Reference Citation Analysis]
76 Hameed H, Farooq M, Vuillier C, Piquet-pellorce C, Hamon A, Dimanche-boitrel M, Samson M, Le Seyec J. RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl4-Induced Liver Injury. IJMS 2022;23:7367. [DOI: 10.3390/ijms23137367] [Reference Citation Analysis]
77 Mcatee C. Drug-Induced Liver Injury. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.04.007] [Reference Citation Analysis]
78 Nie Q, Li C, Wang Y, Hu Y, Pu W, Zhang Q, Cai J, Lin Y, Li G, Wang C, Li L, Dou Y, Zhang J. Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.013] [Reference Citation Analysis]
79 Alshabeeb M, Alomar FA, Khan A. Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury. Front Pharmacol 2022;13:882962. [PMID: 35754504 DOI: 10.3389/fphar.2022.882962] [Reference Citation Analysis]
80 Efe C, Kulkarni AV, Terziroli Beretta-Piccoli B, Magro B, Stättermayer A, Cengiz M, Clayton-Chubb D, Lammert C, Bernsmeier C, Gül Ö, la Tijera FH, Anders M, Lytvyak E, Akın M, Purnak T, Liberal R, Peralta M, Ebik B, Duman S, Demir N, Balaban Y, Urzua Á, Contreras F, Venturelli MG, Bilgiç Y, Medina A, Girala M, Günşar F, Londoño MC, Androutsakos T, Kisch A, Yurci A, Güzelbulut F, Çağın YF, Avcı E, Akyıldız M, Dindar-Demiray EK, Harputluoğlu M, Kumar R, Satapathy SK, Mendizabal M, Silva M, Fagiuoli S, Roberts SK, Soylu NK, Idilman R, Yoshida EM, Montano-Loza AJ, Dalekos GN, Ridruejo E, Schiano TD, Wahlin S. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology 2022;76:1576-86. [PMID: 35567545 DOI: 10.1002/hep.32572] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
81 Mikolajewicz N, Khan S, Trifoi M, Skakdoub A, Ignatchenko V, Mansouri S, Zuccatto J, Zacharia BE, Glantz M, Zadeh G, Moffat J, Kislinger T, Mansouri A. Leveraging the CSF proteome toward minimally-invasive diagnostics and biological characterization of brain malignancies.. [DOI: 10.1101/2022.06.17.22276547] [Reference Citation Analysis]
82 Medina-Montano C, Cacicedo ML, Svensson M, Limeres MJ, Zeyn Y, Chaves-Giraldo JE, Röhrig N, Grabbe S, Gehring S, Bros M. Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation. Int J Mol Sci 2022;23:6543. [PMID: 35742987 DOI: 10.3390/ijms23126543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Liu A, Han N, Munoz-muriedas J, Bender A. Deriving time-concordant event cascades from gene expression data: A case study for Drug-Induced Liver Injury (DILI). PLoS Comput Biol 2022;18:e1010148. [DOI: 10.1371/journal.pcbi.1010148] [Reference Citation Analysis]
84 Ai G, Wu X, Dou Y, Huang R, Zhong L, Liu Y, Xian Y, Lin Z, Li Y, Su Z, Chen J, Qu C. Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway. Food Chem Toxicol 2022;166:113215. [PMID: 35691465 DOI: 10.1016/j.fct.2022.113215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Wang X, Zhao J, Zhang R, Liu X, Ma C, Cao G, Wei Y, Yang P. Protective Effect of Hedyotis diffusa Willd. Ethanol Extract on Isoniazid-Induced Liver Injury in the Zebrafish Model. DDDT 2022;Volume 16:1995-2015. [DOI: 10.2147/dddt.s358498] [Reference Citation Analysis]
86 Feng S, Zheng Z, Gong S, Feng G. A unique probe enables labeling cell membrane and Golgi apparatus and tracking peroxynitrite in Golgi oxidative stress and drug-induced liver injury. Sensors and Actuators B: Chemical 2022;361:131751. [DOI: 10.1016/j.snb.2022.131751] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
87 Chen QW, Li QR, Cao MW, Yan JH, Zhang XZ. Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation. Adv Sci (Weinh) 2022;9:e2200986. [PMID: 35434937 DOI: 10.1002/advs.202200986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Ren Y, Li S, Song Z, Luo Q, Zhang Y, Wang H. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases. Nutrients 2022;14:2303. [PMID: 35684103 DOI: 10.3390/nu14112303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM, Korochanskaya NV, Kucheryavii UA, Lazebnik LB, Livzan MA, Maev IV, Martynov AI, Osipenko MF, Sas EI, Starodubova A, Uspensky YP, Vinnitskaya EV, Yakovenko EP, Yakovlev AA. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. Annals of Medicine 2022;54:1548-60. [DOI: 10.1080/07853890.2022.2069854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
90 Wang YP, Wang YD, Liu YP, Cao JX, Yang ML, Wang YF, Khan A, Zhao TR, Cheng GG. 6'-O-Caffeoylarbutin from Que Zui tea ameliorates acetaminophen-induced liver injury via enhancing antioxidant ability and regulating the PI3K signaling pathway. Food Funct 2022;13:5299-316. [PMID: 35441652 DOI: 10.1039/d2fo00507g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 García-Cortés M, García-García A. Management of Pharmacologic Adverse Effects in Advanced Liver Disease. Clin Drug Investig 2022. [PMID: 35522395 DOI: 10.1007/s40261-022-01150-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Stolz A. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury. Curr Opin Gastroenterol 2022;38:230-8. [PMID: 35645018 DOI: 10.1097/MOG.0000000000000822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Wang T, Hu L, Lu J, Xiao M, Liu J, Xia H, Lu H. Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Yang H, Park T, Park D, Kang M. Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction through changing macrophage polarization. Toxicology in Vitro 2022. [DOI: 10.1016/j.tiv.2022.105374] [Reference Citation Analysis]
95 Dong H, You J, Zhao Y, Zheng D, Zhong Y, Li G, Weng Z, Luo H, Jiang S. Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury. Front Pharmacol 2022;13:838397. [DOI: 10.3389/fphar.2022.838397] [Reference Citation Analysis]
96 Wang S, Bao J, Li J, Li W, Tian M, Qiu C, Pang F, Li X, Yang J, Hu Y, Wang S, Jin H. Fraxinellone Induces Hepatotoxicity in Zebrafish through Oxidative Stress and the Transporters Pathway. Molecules 2022;27:2647. [PMID: 35566003 DOI: 10.3390/molecules27092647] [Reference Citation Analysis]
97 Zhang C, Qiu Z, Zhang L, Wang S, Zhao S, Pang Q, Liang H. Mitochondria-Targeted Fluorescence/Photoacoustic Dual-Modality Imaging Probe Tailored for Visual Precise Diagnosis of Drug-Induced Liver Injury. Anal Chem 2022. [PMID: 35416025 DOI: 10.1021/acs.analchem.2c00041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Mirahmad M, Sabourian R, Mahdavi M, Larijani B, Safavi M. In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation. Drug Metab Rev 2022;:1-76. [PMID: 35403528 DOI: 10.1080/03602532.2022.2064487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Sarma A, Christenson SA, Zha BS, Pisco AO, Neyton LP, Mick E, Sinha P, Wilson JG, Moazed F, Leligdowicz A, Maddali MV, Siegel ER, Lyon Z, Zhou H, Jauregui A, Ghale R, Caldera S, Serpa PH, Deiss T, Love C, Byrne A, Kalantar KL, Derisi JL, Erle DJ, Krummel MF, Kangelaris KN, Hendrickson CM, Woodruff PG, Matthay MA, Langelier CR, Calfee CS, COMET Consortium. Hyperinflammatory ARDS is characterized by interferon-stimulated gene expression, T-cell activation, and an altered metatranscriptome in tracheal aspirates.. [DOI: 10.1101/2022.03.31.22272425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Weisbach L, Schuster AK, Hartmann M, Fromm MF, Maas R, Farker K. Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets. J Clin Med 2022;11:1933. [PMID: 35407541 DOI: 10.3390/jcm11071933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Li M, Gong J, Gao L, Zou T, Kang J, Xu H. Advanced human developmental toxicity and teratogenicity assessment using human organoid models. Ecotoxicol Environ Saf 2022;235:113429. [PMID: 35325609 DOI: 10.1016/j.ecoenv.2022.113429] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
102 Soares PF, Fernandes MTCF, Souza AS, Lopes CM, Dos Santos DAC, Oliveira DPR, Pereira MG, Prado NMBL, Gomes GSDS, Santos G Junior, Paraná R. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review. Ann Hepatol 2021;25:100539. [PMID: 34555512 DOI: 10.1016/j.aohep.2021.100539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Katritsis NM, Liu A, Youssef G, Rathee S, Macmahon M, Hwang W, Wollman L, Han N. dialogi: Utilising NLP with chemical and disease similarities to drive the identification of Drug-Induced Liver Injury literature.. [DOI: 10.1101/2022.03.11.483929] [Reference Citation Analysis]
104 Rodríguez A, García-garcía I, Martínez de Soto L, Gómez López De Las Huertas A, Borobia AM, González-torbay A, Akatbach-bousaid I, González-muñoz M, Ramírez E. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study. Front Pharmacol 2022;13:819589. [DOI: 10.3389/fphar.2022.819589] [Reference Citation Analysis]
105 Contreras Omaña R, Moreno Alcántar R, Cerda Reyes E. Drug-Induced Liver Injury: A Mexican View. Clin Liver Dis (Hoboken) 2022;19:78-81. [PMID: 35308476 DOI: 10.1002/cld.1206] [Reference Citation Analysis]
106 Sakar O, Teker T, Nak SG, Uğraş N. Indomethacin induced toxic hepatitis: a case report. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1072846] [Reference Citation Analysis]
107 Foltin ET, Keller KA. Successful Treatment of Nannizziopsis guarroi Infection Using Systemic Terbinafine in a Central Bearded Dragon (Pogona vitticeps). Journal of Herpetological Medicine and Surgery 2022;32. [DOI: 10.5818/jhms-d-21-00026.2] [Reference Citation Analysis]
108 Brugger M, Laschinger M, Lampl S, Schneider A, Manske K, Esfandyari D, Hüser N, Hartmann D, Steiger K, Engelhardt S, Wohlleber D, Knolle PA. High precision-cut liver slice model to study cell-autonomous anti-viral defense of hepatocytes within their microenvironment. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100465] [Reference Citation Analysis]
109 Zellos A, Debray D, Indolfi G, Czubkowski P, Samyn M, Hadzic N, Gupte G, Fischler B, Smets F, de Cléty SC, Grenda R, Mozer Y, Mancell S, Jahnel J, Auzinger G, Worth A, Lisman T, Staufner C, Baumann U, Dhawan A, Alonso E, Squires RH, Verkade HJ. Proceedings of ESPGHAN Monothematic Conference 2020: "Acute Liver Failure in Children": Diagnosis and Initial Management. J Pediatr Gastroenterol Nutr 2022;74:e45-56. [PMID: 35226643 DOI: 10.1097/MPG.0000000000003341] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Ezquer F, Huang YL, Ezquer M. New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury. Int J Mol Sci 2022;23:2669. [PMID: 35269830 DOI: 10.3390/ijms23052669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Kuula LSM, Backman JT, Blom ML. Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions. Pharmacol Res Perspect 2022;10:e00931. [PMID: 35170862 DOI: 10.1002/prp2.931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Wang F, Zhou J, Chen E. Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis. Front Pharmacol 2022;13:787748. [DOI: 10.3389/fphar.2022.787748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
113 Zhou J, Zheng Q, Chen Z. The Nrf2 Pathway in Liver Diseases. Front Cell Dev Biol 2022;10:826204. [DOI: 10.3389/fcell.2022.826204] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
114 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
115 Björnsson ES, Andrade RJ. Long-term sequelae of drug-induced liver injury. J Hepatol 2022;76:435-45. [PMID: 34688732 DOI: 10.1016/j.jhep.2021.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
116 Chen J, Wu H, Tang X, Chen L. 4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress. Bioengineered 2022;13:2866-77. [PMID: 35045794 DOI: 10.1080/21655979.2021.2024970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Yu Z, Wu Z, Li W, Liu G, Tang Y. ADENet: a novel network-based inference method for prediction of drug adverse events. Brief Bioinform 2022:bbab580. [PMID: 35039845 DOI: 10.1093/bib/bbab580] [Reference Citation Analysis]
118 Blanquicett A, Martinez-ávila MC, Mondol Z, Imbeth Acosta P. Toxic Hepatitis Associated With the Use of Contraceptives: A Diagnosis to Bear in Mind. Cureus 2022. [DOI: 10.7759/cureus.21220] [Reference Citation Analysis]
119 Akçay Ö, Gümüştekin M. Voriconazole-Induced Hepatotoxicity Concise up-to-date review. Journal of Basic and Clinical Health Sciences. [DOI: 10.30621/jbachs.1051669] [Reference Citation Analysis]
120 Wang S, Zhang L, Luo Y, Bai Y, Huang Y, Zhao S. A Circular Dichroism and Photoacoustic Dual-Mode Probe for Detection In Vitro and Imaging In Vivo of Hydroxyl Radicals. Anal Chem . [DOI: 10.1021/acs.analchem.1c04237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Liu L, Yang Y, Li W, Li Y, Jiang X, Wang L. Tanshinone IIA alleviate rifampicin-induced cholestasis by regulating the expression and function of bile salt export pump. Hum Exp Toxicol 2022;41:9603271221097365. [PMID: 35544702 DOI: 10.1177/09603271221097365] [Reference Citation Analysis]
122 Deng J, Fu Z, Wang L, Liu J, Chen C, Fang F, Wang X. Acute liver failure associated with lamotrigine in children with epilepsy: A report of two cases and thoughts on pharmacogenomics. Epilepsy & Behavior Reports 2022;20:100568. [DOI: 10.1016/j.ebr.2022.100568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Karlsen TH, Sheron N, Zelber-Sagi S, Carrieri P, Dusheiko G, Bugianesi E, Pryke R, Hutchinson SJ, Sangro B, Martin NK, Cecchini M, Dirac MA, Belloni A, Serra-Burriel M, Ponsioen CY, Sheena B, Lerouge A, Devaux M, Scott N, Hellard M, Verkade HJ, Sturm E, Marchesini G, Yki-Järvinen H, Byrne CD, Targher G, Tur-Sinai A, Barrett D, Ninburg M, Reic T, Taylor A, Rhodes T, Treloar C, Petersen C, Schramm C, Flisiak R, Simonova MY, Pares A, Johnson P, Cucchetti A, Graupera I, Lionis C, Pose E, Fabrellas N, Ma AT, Mendive JM, Mazzaferro V, Rutter H, Cortez-Pinto H, Kelly D, Burton R, Lazarus JV, Ginès P, Buti M, Newsome PN, Burra P, Manns MP. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 2022;399:61-116. [PMID: 34863359 DOI: 10.1016/S0140-6736(21)01701-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 66] [Article Influence: 53.0] [Reference Citation Analysis]
124 Li Y, Zhou H. Drug-Induced Liver Injury. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00008-6] [Reference Citation Analysis]
125 Ding W, Wang H, Zhang Y. Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.002] [Reference Citation Analysis]
126 Uetrecht J, Grant DM, Wells PG. Biochemical mechanisms of drug toxicity. Atkinson's Principles of Clinical Pharmacology 2022. [DOI: 10.1016/b978-0-12-819869-8.00015-x] [Reference Citation Analysis]
127 Atallah E, Aithal GP. Drug-Induced Liver Injury. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_3] [Reference Citation Analysis]
128 Vazquez JH, McGill MR. Redrawing the map to novel DILI biomarkers in circulation: Where are we, where should we go, and how can we get there? Livers 2021;1:286-93. [PMID: 34966905 DOI: 10.3390/livers1040022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
129 Caballano-infantes E, García-garcía A, Lopez-gomez C, Cueto A, Robles-diaz M, Ortega-alonso A, Martín-reyes F, Alvarez-alvarez I, Arranz-salas I, Ruiz-cabello F, Lucena IM, García-fuentes E, Andrade RJ, García-cortes M. Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury. Biomedicines 2022;10:55. [DOI: 10.3390/biomedicines10010055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Ore A, Adeogun AI, Akinloye OA. Hydroethanolic Extract of Defatted Buchholzia coriacea Seeds Alleviates Tamoxifen-Induced Hepatic Triglyceride Accumulation, Inflammation and Oxidative Distress in Rat. Medicines 2021;9:1. [DOI: 10.3390/medicines9010001] [Reference Citation Analysis]
131 Wu Y, Liu Z, Wu L, Chen M, Tong W. BERT-Based Natural Language Processing of Drug Labeling Documents: A Case Study for Classifying Drug-Induced Liver Injury Risk. Front Artif Intell 2021;4:729834. [PMID: 34939028 DOI: 10.3389/frai.2021.729834] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
132 Volynets GV, Khavkin AI. Inflammatory bowel disease and drug-induced liver damage. jour 2021. [DOI: 10.31146/1682-8658-ecg-194-10-138-146] [Reference Citation Analysis]
133 Okonechnikov K, Joshi P, Sepp M, Leiss K, Sarropoulos I, Murat F, Sill M, Beck P, Chan KC, Korshunov A, Sahm F, Deng MY, Sturm D, Desisto J, Donson AM, Foreman NK, Green AL, Robinson G, Orr BA, Gao Q, Darrow E, Hadley JL, Northcott PA, Gojo J, Ryzhova M, Kawauchi D, Hovestadt V, Filbin MG, Deimling AV, Zuckermann M, Pajtler KW, Kool M, Jones DT, Jäger N, Kutscher LM, Kaessmann H, Pfister SM. Mapping pediatric brain tumors to their origins in the developing cerebellum.. [DOI: 10.1101/2021.12.19.473154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
134 Ntamo Y, Ziqubu K, Chellan N, Nkambule BB, Nyambuya TM, Mazibuko-Mbeje SE, Gabuza KB, Marcheggiani F, Tiano L, Dludla PV. Drug-Induced Liver Injury: Clinical Evidence of N-Acetyl Cysteine Protective Effects. Oxid Med Cell Longev 2021;2021:3320325. [PMID: 34912495 DOI: 10.1155/2021/3320325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
135 Pais JP, Mota R, Cruz M, Cambão AR, Nascimento A. Drug-Induced Liver Injury Induced by Bioflavonoids. Cureus 2021. [DOI: 10.7759/cureus.20453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Thomas S, Wierenga K, Pestka J, Olive AJ. FLAMs: A self-replicating ex vivo model of alveolar macrophages for functional genetic studies.. [DOI: 10.1101/2021.12.12.472259] [Reference Citation Analysis]
137 Mountford PA, Leiphrakpam PD, Weber HR, Mccain A, Scribner RM, Scribner RT, Duarte EM, Chen J, Borden MA, Buesing KL. Colonic Oxygen Microbubbles Augment Systemic Oxygenation and CO2 Removal in a Porcine Smoke Inhalation Model of Severe Hypoxia.. [DOI: 10.1101/2021.12.08.466665] [Reference Citation Analysis]
138 Chen Z, Jiang Y, Zhang X, Zheng R, Qiu R, Sun Y, Zhao C, Shang H. ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18. Brief Bioinform 2021:bbab503. [PMID: 34882224 DOI: 10.1093/bib/bbab503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
139 Debortoli C, Lan R, Lafont J, Campana F, Catherine J. Paracetamol misusing to dental pain: a case-report and recommandations for treatment. J Oral Med Oral Surg 2021;27:57. [DOI: 10.1051/mbcb/2021042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Beier JI, Arteel GE. Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns. Acta Pharm Sin B 2021;11:3768-78. [PMID: 35024305 DOI: 10.1016/j.apsb.2021.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551 [PMID: 34904028 DOI: 10.4254/wjh.v13.i11.1534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
142 Meng L, Wang Q, Wang L, Zhao Z, Xin GZ, Zheng Z, Zhou P, Li P, Jiang Y, Li HJ. miR122-controlled all-in-one nanoplatform for in situ theranostic of drug-induced liver injury by visualization imaging guided on-demand drug release. Mater Today Bio 2021;12:100157. [PMID: 34825161 DOI: 10.1016/j.mtbio.2021.100157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Villanueva-Paz M, Niu H, Segovia-Zafra A, Medina-Caliz I, Sanabria-Cabrera J, Lucena MI, Andrade RJ, Alvarez-Alvarez I. Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions. J Clin Med 2021;10:5317. [PMID: 34830594 DOI: 10.3390/jcm10225317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
144 Wang J, Buchman CD, Seetharaman J, Miller DJ, Huber AD, Wu J, Chai SC, Garcia-Maldonado E, Wright WC, Chenge J, Chen T. Unraveling the Structural Basis of Selective Inhibition of Human Cytochrome P450 3A5. J Am Chem Soc 2021;143:18467-80. [PMID: 34648292 DOI: 10.1021/jacs.1c07066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Karaaslanli A, Saha S, Aviyente S, Maiti T. Multiview Graph Learning for single-cell RNA sequencing data.. [DOI: 10.1101/2021.11.05.467476] [Reference Citation Analysis]
146 Anselm V, Sommersdorf C, Carrasco-Triguero M, Katavolos P, Planatscher H, Steinhilber A, Joos T, Poetz O. Matrix and Sampling Effects on Quantification of Protein Biomarkers of Drug-Induced Liver Injury. J Proteome Res 2021;20:4985-94. [PMID: 34554759 DOI: 10.1021/acs.jproteome.1c00478] [Reference Citation Analysis]
147 Deng J, Yang Z, Ojima I, Samaras D, Wang F. Artificial intelligence in drug discovery: applications and techniques. Brief Bioinform 2021:bbab430. [PMID: 34734228 DOI: 10.1093/bib/bbab430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
148 Roman A, Moldovan S, Santini A, Stoian M, Dobru D. Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak. J Crit Care Med (Targu Mures) 2021;7:211-6. [PMID: 34722924 DOI: 10.2478/jccm-2021-0021] [Reference Citation Analysis]
149 Moreira JLS, Barbosa SMB, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. [PMID: 34303828 DOI: 10.1016/j.clinre.2021.101752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
150 Garcia-Ruiz C, Fernandez-Checa JC. C-Reactive Protein, a Promising Approach for Acetaminophen Hepatotoxicity. Cell Mol Gastroenterol Hepatol 2022;13:341-2. [PMID: 34732318 DOI: 10.1016/j.jcmgh.2021.10.004] [Reference Citation Analysis]
151 Cui R, Wang C, Li T, Hua J, Zhao T, Ren L, Wang Y, Li Y. Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer. Cancer Cell Int 2021;21:571. [PMID: 34711246 DOI: 10.1186/s12935-021-02256-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
152 Tu C, Gao Y, Song D, Niu M, Ma RR, Zhou MX, He X, Xiao XH, Wang JB. Screening for Susceptibility-Related Biomarkers of Diclofenac-Induced Liver Injury in Rats Using Metabolomics. Front Pharmacol 2021;12:693928. [PMID: 34630079 DOI: 10.3389/fphar.2021.693928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Moore R, Ashby K, Liao TJ, Chen M. Machine Learning to Identify Interaction of Single-Nucleotide Polymorphisms as a Risk Factor for Chronic Drug-Induced Liver Injury. Int J Environ Res Public Health 2021;18:10603. [PMID: 34682349 DOI: 10.3390/ijerph182010603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
154 Kumar VS, Dhananjaya S, Gowda S. Tuberculosis treatment spills the beans on Wilson’s disease and more. Medical Journal Armed Forces India 2021. [DOI: 10.1016/j.mjafi.2021.08.018] [Reference Citation Analysis]
155 Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, Garcia-Ruiz C, Konu O, Miranda J, Lunov O, Dejneka A, Elfick A, McDonald A, Sullivan GJ, Aithal GP, Lucena MI, Andrade RJ, Fromenty B, Kranendonk M, Cubero FJ, Nelson LJ. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J Hepatol 2021;75:935-59. [PMID: 34171436 DOI: 10.1016/j.jhep.2021.06.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
156 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
157 Liu A, Han N, Munoz-muriedas J, Bender A. Deriving time-concordant event cascades from gene expression data: A case study for Drug-Induced Liver Injury (DILI).. [DOI: 10.1101/2021.09.23.461089] [Reference Citation Analysis]
158 Li HY, Tang ZM, Wang Z, Lv JM, Liu XL, Liang YL, Cheng B, Gao N, Ji SR, Wu Y. C-Reactive Protein Protects Against Acetaminophen-Induced Liver Injury by Preventing Complement Overactivation. Cell Mol Gastroenterol Hepatol 2022;13:289-307. [PMID: 34536564 DOI: 10.1016/j.jcmgh.2021.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
159 Adeluwa T, McGregor BA, Guo K, Hur J. Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors. Front Pharmacol 2021;12:648805. [PMID: 34483896 DOI: 10.3389/fphar.2021.648805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Li ZB, Chen DD, He QJ, Li L, Zhou G, Fu YM, Deng Y, Niu XX, Chu F, Gao XP, Zou Z, Chen G, Ji D. The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study. Front Pharmacol 2021;12:734090. [PMID: 34483945 DOI: 10.3389/fphar.2021.734090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Shankarappa D, Jafrin A L, B J, B M. HEPATOPROTECTIVE EFFECT OF MELATONIN ON PARACETAMOL INDUCED HEPATOTOXICITY IN ALBINO RATS. Asian J Pharm Clin Res 2021. [DOI: 10.22159/ajpcr.2021.v14i9.42539] [Reference Citation Analysis]
162 Xiao RR, Lv T, Tu X, Li P, Wang T, Dong H, Tu P, Ai X. An integrated biomimetic array chip for establishment of collagen-based 3D primary human hepatocyte model for prediction of clinical drug-induced liver injury. Biotechnol Bioeng 2021;118:4687-98. [PMID: 34478150 DOI: 10.1002/bit.27931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
163 Pineda Salgado L, Gupta R, Jan M, Turkoglu O, Estilo A, George V, Rahman MI. Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database. Adv Ther 2021;38:4709-21. [PMID: 34319549 DOI: 10.1007/s12325-021-01856-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Dong H, You J, Zhao Y, Zheng D, Zhong Y, Weng Z, Luo H, Jiang S. Association Between the Characteristics of Small-molecule Kinase Inhibitors and Drug-induced Liver Injury: A Scoping Study (Preprint).. [DOI: 10.2196/preprints.33257] [Reference Citation Analysis]
165 Xiong Y, Huang J. Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment. Chin Med 2021;16:80. [PMID: 34407830 DOI: 10.1186/s13020-021-00489-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Niu B, Lei X, Xu Q, Ju Y, Xu D, Mao L, Li J, Zheng Y, Sun N, Zhang X, Mao Y, Li X. Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. Cell Biol Toxicol 2021. [PMID: 34401974 DOI: 10.1007/s10565-021-09624-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
167 Murphy WA, Saran C, Honkakoski P, Brouwer KL. Mechanism‐Based Experimental Models for the Evaluation of BSEP Inhibition and DILI. Transporters and Drug‐Metabolizing Enzymes in Drug Toxicity 2021. [DOI: 10.1002/9781119171003.ch9] [Reference Citation Analysis]
168 Zheng J, Zhou H, Yang T, Liu J, Qin T, Gu X, Wu J, Zhang Y, Wang H, Tang Y, Xue F, Mao Y, Xia Q. Protective Role of microRNA-31 in Acetaminophen-Induced Liver Injury: A Negative Regulator of c-Jun N-Terminal Kinase (JNK) Signaling Pathway. Cell Mol Gastroenterol Hepatol 2021;12:1789-807. [PMID: 34311140 DOI: 10.1016/j.jcmgh.2021.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Xie L, Xu J, Guo W, Wang Z, Yao Y, Li J, Lin J, Xiao J, Yu X, Zhang W, Cai Z, Hua Y, Chen J, Shao Z, Wu D, Wu S, Tu Z, Zhang X. Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience. Front Oncol 2021;11:696865. [PMID: 34367981 DOI: 10.3389/fonc.2021.696865] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
170 García-Cortés M, Ortega-Alonso A, Andrade RJ. Safety of treating acute liver injury and failure. Expert Opin Drug Saf 2021;:1-13. [PMID: 34254839 DOI: 10.1080/14740338.2021.1955854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Quintás G, Martínez-Sena T, Conde I, Pareja Ibars E, Kleinjans J, Castell JV. Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes. Arch Toxicol 2021;95:3049-62. [PMID: 34274980 DOI: 10.1007/s00204-021-03114-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
172 Yang CX, Yao DM. Research advances in pathogenesis and diagnostic markers of drug-induced liver injury. Shijie Huaren Xiaohua Zazhi 2021; 29(13): 726-732 [DOI: 10.11569/wcjd.v29.i13.726] [Reference Citation Analysis]
173 Bouhlali EDT, Derouich M, Hmidani A, Bourkhis B, Khouya T, Filali-Zegzouti Y, Alem C. Protective Effect of Phoenix dactylifera L. Seeds against Paracetamol-Induced Hepatotoxicity in Rats: A Comparison with Vitamin C. ScientificWorldJournal 2021;2021:6618273. [PMID: 34326710 DOI: 10.1155/2021/6618273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, Gonzalez-Jimenez A, Alvarez-Alvarez I, Slim M, Jimenez-Perez M, Gonzalez-Grande R, Fernández MC, Casado M, Soriano G, Román E, Hallal H, Romero-Gomez M, Castiella A, Conde I, Prieto M, Moreno-Planas JM, Giraldez A, Moreno-Sanfiel JM, Kaplowitz N, Lucena MI, Andrade RJ; Participating clinical centres. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol 2021;75:86-97. [PMID: 33539847 DOI: 10.1016/j.jhep.2021.01.029] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
175 Jiang T, Guo H, Xia YN, Liu Y, Chen D, Pang G, Feng Y, Yu H, Wu Y, Zhang S, Wang Y, Wang Y, Wen H, Zhang LW. Hepatotoxicity of copper sulfide nanoparticles towards hepatocyte spheroids using a novel multi-concave agarose chip method. Nanomedicine (Lond) 2021;16:1487-504. [PMID: 34184559 DOI: 10.2217/nnm-2021-0011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Ezhilarasan D. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms. Toxicology 2021;458:152840. [PMID: 34175381 DOI: 10.1016/j.tox.2021.152840] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
177 Gracia-Sancho J, Caparrós E, Fernández-Iglesias A, Francés R. Role of liver sinusoidal endothelial cells in liver diseases. Nat Rev Gastroenterol Hepatol 2021;18:411-31. [PMID: 33589830 DOI: 10.1038/s41575-020-00411-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 29.0] [Reference Citation Analysis]
178 Itay A, Yoav L, Ariel K, Shoshana Z, Ina G, Elad R, Shimon S, Tali B, David E K. Characterization of patients diagnosed with drug-induced liver injury. Arch Clin Gastroenterol 2021. [DOI: 10.17352/2455-2283.000095] [Reference Citation Analysis]
179 Yan X, Lin W, Liu H, Pu W, Li J, Wu P, Ding J, Luo G, Zhang J. Wavelength-Tunable, Long Lifetime, and Biocompatible Luminescent Nanoparticles Based on a Vitamin E-Derived Material for Inflammation and Tumor Imaging. Small 2021;17:e2100045. [PMID: 34031977 DOI: 10.1002/smll.202100045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
180 Sernoskie SC, Jee A, Uetrecht JP. The Emerging Role of the Innate Immune Response in Idiosyncratic Drug Reactions. Pharmacol Rev 2021;73:861-96. [PMID: 34016669 DOI: 10.1124/pharmrev.120.000090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
181 Zhuo Y, Zhang Y, Li M, Wu H, Gong S, Hu X, Fu Y, Shen X, Sun B, Wu JL, Li N. Hepatotoxic evaluation of toosendanin via biomarker quantification and pathway mapping of large-scale chemical proteomics. Food Chem Toxicol 2021;153:112257. [PMID: 34000341 DOI: 10.1016/j.fct.2021.112257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
182 Sipos M, Farcas A, Leucuta DC, Bucsa C, Huruba M, Mogosan C. Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly. Pharmaceuticals (Basel) 2021;14:441. [PMID: 34067178 DOI: 10.3390/ph14050441] [Reference Citation Analysis]
183 Kumar N, Surani S, Udeani G, Mathew S, John S, Sajan S, Mishra J. Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies. Life Sci 2021;278:119544. [PMID: 33945827 DOI: 10.1016/j.lfs.2021.119544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
184 Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR; Practice Parameters Committee of the American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Am J Gastroenterol 2021;116:878-98. [PMID: 33929376 DOI: 10.14309/ajg.0000000000001259] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 29.5] [Reference Citation Analysis]
185 Peng W, Cheng S, Bao Z, Wang Y, Zhou W, Wang J, Yang Q, Chen C, Wang W. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021;137:111342. [DOI: 10.1016/j.biopha.2021.111342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
186 Liu T, Tian M, Wang J, Tian X, Liu J, Feng L, Ma X, Cui J. Rational design of a fluorescent probe for the detection of LAP and its application in drug-induced liver injury. Spectrochim Acta A Mol Biomol Spectrosc 2021;251:119362. [PMID: 33486435 DOI: 10.1016/j.saa.2020.119362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
187 Du HJ, Zhao SX, Zhao W, Fu N, Li WC, Qin XJ, Zhang YG, Nan YM, Zhao JM. Hepatic Macrophage activation and the LPS pathway in patients with different degrees of severity and histopathological patterns of drug induced liver injury. Histol Histopathol 2021;36:653-62. [PMID: 33870482 DOI: 10.14670/HH-18-340] [Reference Citation Analysis]
188 Wang H, Liu C, He Z, Li P, Zhang W, Zhang W, Tang B. Dual-Colored Fluorescence Imaging of Mitochondrial HNO and Golgi-HNO in Mice with DILI. Anal Chem 2021;93:6551-8. [PMID: 33848128 DOI: 10.1021/acs.analchem.1c00742] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
189 Lee BT, Odin JA, Grewal P. An Approach to Drug-Induced Liver Injury from the Geriatric Perspective. Curr Gastroenterol Rep 2021;23:6. [PMID: 33846832 DOI: 10.1007/s11894-021-00804-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
190 Mazzolari A, Sommaruga L, Pedretti A, Vistoli G. MetaTREE, a Novel Database Focused on Metabolic Trees, Predicts an Important Detoxification Mechanism: The Glutathione Conjugation. Molecules 2021;26:2098. [PMID: 33917533 DOI: 10.3390/molecules26072098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Xia C, Liu Y, Yao H, Zhu W, Ding J, Jin J. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature. J Int Med Res 2020;48:300060520917569. [PMID: 32293220 DOI: 10.1177/0300060520917569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
192 Bessone F, Hernandez N, Mendizabal M, Ridruejo E, Gualano G, Fassio E, Peralta M, Fainboim H, Anders M, Tanno H, Tanno F, Parana R, Medina-Caliz I, Robles-Diaz M, Alvarez-Alvarez I, Niu H, Stephens C, Colombato L, Arrese M, Reggiardo MV, Ono SK, Carrilho F, Lucena MI, Andrade RJ. Serious liver injury induced by Nimesulide: an international collaborative study. Arch Toxicol 2021;95:1475-87. [PMID: 33759010 DOI: 10.1007/s00204-021-03000-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
193 Koroglu OF, Gunata M, Vardi N, Yildiz A, Ates B, Colak C, Tanriverdi LH, Parlakpinar H. Protective effects of naringin on valproic acid-induced hepatotoxicity in rats. Tissue Cell 2021;72:101526. [PMID: 33756270 DOI: 10.1016/j.tice.2021.101526] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
194 Moradi M, Goodarzi N, Faramarzi A, Cheraghi H, Hashemian AH, Jalili C. Melatonin protects rats testes against bleomycin, etoposide, and cisplatin-induced toxicity via mitigating nitro-oxidative stress and apoptosis. Biomed Pharmacother 2021;138:111481. [PMID: 33752059 DOI: 10.1016/j.biopha.2021.111481] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
195 Jee A, Sernoskie SC, Uetrecht J. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges. Int J Mol Sci 2021;22:2954. [PMID: 33799477 DOI: 10.3390/ijms22062954] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
196 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
197 Gonzalez-Jimenez A, Suzuki A, Chen M, Ashby K, Alvarez-Alvarez I, Andrade RJ, Lucena MI. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach. Arch Toxicol 2021;95:1793-803. [PMID: 33666709 DOI: 10.1007/s00204-021-03013-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Tu C, Niu M, Wei AW, Tang JF, Zhang L, Jing J, Xiao XH, Wang JB. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. J Inflamm Res 2021;14:645-55. [PMID: 33692634 DOI: 10.2147/JIR.S299892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
199 Chen Y, Wang C, Yang H, Huang P, Shi J, Tong Y, Jiang J, Zhang X, Chen W, Xuan Z. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Biomed Res Int 2021;2021:8894498. [PMID: 33954202 DOI: 10.1155/2021/8894498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
200 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
201 Zeiss R, Gahr M. Relevante Aspekte der arzneimittelassoziierten Hepatotoxizität im klinischen Alltag. Nervenheilkunde 2021;40:43-47. [DOI: 10.1055/a-1300-7298] [Reference Citation Analysis]
202 Niu H, Sanabria-cabrera J, Alvarez-alvarez I, Robles-diaz M, Stankevičiūtė S, Aithal GP, Björnsson ES, Andrade RJ, Lucena MI. Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials. Pharmacological Research 2021;164:105404. [DOI: 10.1016/j.phrs.2020.105404] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
203 McLoughlin KS, Jeong CG, Sweitzer TD, Minnich AJ, Tse MJ, Bennion BJ, Allen JE, Calad-Thomson S, Rush TS, Brase JM. Machine Learning Models to Predict Inhibition of the Bile Salt Export Pump. J Chem Inf Model 2021;61:587-602. [PMID: 33502191 DOI: 10.1021/acs.jcim.0c00950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
204 Abdolalizadeh A, Moradi K, Dabbagh Ohadi MA, Mirfazeli F, Rajimehr R. Childhood Conduct History is Linked to Amygdalohippocampal Changes in Healthy Adults: A Neuroimaging Behavioral Study.. [DOI: 10.1101/2021.01.20.21250107] [Reference Citation Analysis]
205 Beachler DC, de Luise C, Jamal-Allial A, Yin R, Taylor DH, Suzuki A, Lewis JH, Freston JW, Lanes S. Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study. BMC Cancer 2021;21:97. [PMID: 33494720 DOI: 10.1186/s12885-021-07790-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
206 Wang J, Qiao W, Li X, Zhao H, Zhang H, Dong A, Yang X. A directed co-assembly of herbal small molecules into carrier-free nanodrugs for enhanced synergistic antitumor efficacy. J Mater Chem B 2021;9:1040-8. [PMID: 33392615 DOI: 10.1039/d0tb02071k] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
207 Kumar P, Reddy S, Kulkarni A, Sharma M, Rao PN. Cyproterone Acetate-Induced Acute Liver Failure: A Case Report and Review of the Literature. J Clin Exp Hepatol 2021;11:739-41. [PMID: 34866850 DOI: 10.1016/j.jceh.2021.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 Janković S, Popovska-jovičić B, Pavlović R, Živković-zarić R. DRESS syndrome without eosinophilia induced by Carbamazepine: A case report. Hosp Pharm Int Multi J 2021;8:1083-1089. [DOI: 10.5937/hpimj2103083j] [Reference Citation Analysis]
209 Kharchenko YV, Dychko YN, Topka EG, Kosse VA, Lyulko IV, Alekseenko ZK, Filippov YO. GUT MICROBIOTA IN THE PATHOLOGY AND PREVENTION OF LIVER DISEASE. VPBM 2021;3:81. [DOI: 10.29254/2077-4214-2021-3-161-81-89] [Reference Citation Analysis]
210 Ezhilarasan D. Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives. Eur J Pharmacol 2021;893:173832. [PMID: 33359144 DOI: 10.1016/j.ejphar.2020.173832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
211 Jüngst C, Kullak-ublick GA. Toxische Lebererkrankungen. Therapie-Handbuch - Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-23847-5.00049-1] [Reference Citation Analysis]
212 Wu SY, Wang WJ, Dou JH, Gong LK. Research progress on the protective effects of licorice-derived 18β-glycyrrhetinic acid against liver injury. Acta Pharmacol Sin 2021;42:18-26. [PMID: 32144337 DOI: 10.1038/s41401-020-0383-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
213 Li T, Tong W, Roberts R, Liu Z, Thakkar S. DeepDILI: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation. Chem Res Toxicol 2021;34:550-65. [PMID: 33356151 DOI: 10.1021/acs.chemrestox.0c00374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
214 Li C, Hu Y, Nie Q, Chen S, Li G, Li L, Chen S, Tang B, Zhang J. A reactive oxygen species-responsive antioxidant nanotherapy for the treatment of drug-induced tissue and organ injury. Biomater Sci 2020;8:7117-31. [PMID: 33211787 DOI: 10.1039/d0bm01660h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
215 Stephens C, Lucena MI, Andrade RJ. Genetic risk factors in the development of idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2021;17:153-69. [DOI: 10.1080/17425255.2021.1854726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
216 Umbaugh DS, Jaeschke H. Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity. Expert Rev Gastroenterol Hepatol 2021;15:363-75. [PMID: 33242385 DOI: 10.1080/17474124.2021.1857238] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
217 Weersink RA, Alvarez-Alvarez I, Medina-Cáliz I, Sanabria-Cabrera J, Robles-Díaz M, Ortega-Alonso A, García-Cortés M, Bonilla E, Niu H, Soriano G, Jimenez-Perez M, Hallal H, Blanco S, Kaplowitz N, Lucena MI, Andrade RJ. Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old.Clin Pharmacol Ther. 2021;109:1147-1158. [PMID: 33179256 DOI: 10.1002/cpt.2108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
218 Lv R, Shi R, Wu E, Ma C, Guo R, Li J, Ouyang F, Fang Q, Hu L, Sun C, Liu Y, Kang Z, Liu J. Spatial-temporal profiling of antibiotic metabolites using graphite dots-assisted laser desorption ionization mass spectrometry. Talanta 2020;220:121371. [DOI: 10.1016/j.talanta.2020.121371] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
219 Li T, Tong W, Roberts R, Liu Z, Thakkar S. Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury. Front Bioeng Biotechnol 2020;8:562677. [PMID: 33330410 DOI: 10.3389/fbioe.2020.562677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
220 Watkins PB, Church RJ, Li J, Knappertz V. Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial. Clin Pharmacol Ther 2021;109:1224-31. [PMID: 33022751 DOI: 10.1002/cpt.2071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
221 Watkins PB. DILIsym: Quantitative systems toxicology impacting drug development. Current Opinion in Toxicology 2020;23-24:67-73. [DOI: 10.1016/j.cotox.2020.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Umbaugh DS, Jaeschke H. Extracellular vesicles: Roles and applications in drug-induced liver injury. Adv Clin Chem 2021;102:63-125. [PMID: 34044913 DOI: 10.1016/bs.acc.2020.08.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
223 Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327:641-66. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
224 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
225 Lucena MI, Sanabria J, García-cortes M, Stephens C, Andrade RJ. Drug-induced liver injury in older people. The Lancet Gastroenterology & Hepatology 2020;5:862-74. [DOI: 10.1016/s2468-1253(20)30006-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
226 Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update.Arch Toxicol. 2020;94:3381-3407. [PMID: 32852569 DOI: 10.1007/s00204-020-02885-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
227 Krajnc E, Visentin M, Gai Z, Stieger B, Samodelov SL, Häusler S, Kullak-Ublick GA. Untargeted Metabolomics Reveals Anaerobic Glycolysis as a Novel Target of the Hepatotoxic Antidepressant Nefazodone. J Pharmacol Exp Ther 2020;375:239-46. [PMID: 32848075 DOI: 10.1124/jpet.120.000120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
228 Oda S, Uchida Y, Aleo MD, Koza-Taylor PH, Matsui Y, Hizue M, Marroquin LD, Whritenour J, Uchida E, Yokoi T. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol 2021;95:149-68. [PMID: 32816093 DOI: 10.1007/s00204-020-02882-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
229 Li C, Dou Y, Chen Y, Qi Y, Li L, Han S, Jin T, Guo J, Chen J, Zhang J. Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity. Adv Funct Mater 2020;30:2002131. [DOI: 10.1002/adfm.202002131] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
230 Yang G, Wu P, Yu C, Zhang J, Song J. Facile Engineering of Anti‐Inflammatory Nanotherapies by Host‐Guest Self‐Assembly. ChemistrySelect 2020;5:8707-16. [DOI: 10.1002/slct.202001590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
231 Restrepo-gutiérrez JC. DILI: un desafío. Hepatología 2020. [DOI: 10.52784/27112330.118] [Reference Citation Analysis]
232 Barnhill MS, Steinberg JM, Jennings JJ, Lewis JH. Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 Update. Curr Gastroenterol Rep 2020;22:47. [PMID: 32671616 DOI: 10.1007/s11894-020-00781-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
233 Walles M, Brown AP, Zimmerlin A, End P. New Perspectives on Drug-Induced Liver Injury Risk Assessment of Acyl Glucuronides. Chem Res Toxicol 2020;33:1551-60. [PMID: 32525307 DOI: 10.1021/acs.chemrestox.0c00131] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
234 da Costa Junior LC, de Castro CL, Freitas-Alves DR, Vianna-Jorge R, Santos PCJL. ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers. Eur J Clin Pharmacol 2020;76:1401-8. [PMID: 32564116 DOI: 10.1007/s00228-020-02934-9] [Reference Citation Analysis]
235 Li CY, Niu M, Liu YL, Tang JF, Chen W, Qian G, Zhang MY, Shi YF, Lin JZ, Li XJ, Li RS, Xiao XH, Li GH, Wang JB. Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury. Front Pharmacol 2020;11:810. [PMID: 32547402 DOI: 10.3389/fphar.2020.00810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
236 Wang J, Bwayi M, Gee RRF, Chen T. PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches. Expert Opin Drug Metab Toxicol 2020;16:711-22. [PMID: 32500752 DOI: 10.1080/17425255.2020.1779701] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
237 Sun HJ, Wu ZY, Nie XW, Wang XY, Bian JS. Implications of hydrogen sulfide in liver pathophysiology: Mechanistic insights and therapeutic potential. J Adv Res 2021;27:127-35. [PMID: 33318872 DOI: 10.1016/j.jare.2020.05.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
238 Kaplan M, Akpinar MY, Coşkun O, Aksoy A, Gökbulut V. Didrogesterone-Induced Toxic Hepatitis: A Case Report. Ahi Evran Medical Journal 2020;4:21-23. [DOI: 10.46332/aemj.626178] [Reference Citation Analysis]
239 Zhang C, Jin H, Wang Y, Li C, Zhao X, Li Y, Shi W, Tian Y, Xu H, Tian D, Liu K, Jia J, Sun G, Zhang D. Critical role of OX40 in drug-induced acute liver injury. Br J Pharmacol 2020;177:3183-96. [PMID: 32133635 DOI: 10.1111/bph.15041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
240 Wang X, Chen X. Clinical Characteristics of 162 Patients with Drug-Induced Liver and/or Kidney Injury. Biomed Res Int 2020;2020:3930921. [PMID: 32051826 DOI: 10.1155/2020/3930921] [Reference Citation Analysis]
241 Ma H, Chen S, Xiong H, Wang M, Hang W, Zhu X, Zheng Y, Ge B, Li R, Cui H. Astaxanthin from Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1/Nrf2/HO-1 pathway in mice. Food Funct 2020;11:4659-71. [DOI: 10.1039/c9fo02429h] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
242 Meng L, Zheng X, Zheng Z, Zhao Z, Wang L, Zhou P, Xin G, Li P, Li H. A sensitive upconverting nanoprobe based on signal amplification technology for real-time in situ monitoring of drug-induced liver injury. Nanoscale 2020;12:15325-35. [DOI: 10.1039/d0nr01493a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
243 Wang J, Qiao W, Zhao H, Cheng J, Han Y, Yang X. A highly atom-economical bioactive nanocarrier for synergistically enhanced antitumor with reduced liver injury. New J Chem 2020;44:16741-51. [DOI: 10.1039/d0nj04029k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]